Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term drug-resistance. Found 18 abstracts

Chen JJ, Sun YL, Tiwari AK, Xiao ZJ, Sodani K, Yang DH, Vispute SG, Jiang WQ, Chen SD, Chen ZS. PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter. Cancer Science. 2012 Aug;103(8):1531-7.   PMCID: PMC3407321[Available on 2013/8/1]
Malofeeva EV, Domanitskaya N, Gudima M, Hopper-Borge EA. Modulation of the ATPase and Transport Activities of Broad-Acting Multidrug Resistance Factor ABCC10 (MRP7). Cancer Research. 2012 Dec;72(24):6457-67.   PMCID: PMC 3525726
Kuang YH, Shen T, Chen X, Sodani K, Hopper-Borge E, Tiwari AK, Lee J, Fu LW, Chen ZS. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance. Biochemical pharmacology. 2010 Jan;79(2):154-61.   PMCID: PMC2953260
Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Pass HI, Carbone M, Testa JR, Mossman BT. Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin - art. no. 314. Molecular Cancer. 2010 Dec;9:314.   PMCID: PMC3016286
Liu H, Cheng D, Weichel AK, Osipo C, Wing LK, Chen B, Louis TE, Jordan VC. Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cells. INTERNATIONAL JOURNAL OF ONCOLOGY. 2006 Nov;29(5):1237-46.
Sharma V, Prior JL, Belinsky MG, Kruh GD, Piwnica-Worms D. Characterization of a Ga-67/Ga-68 radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: Validation in multidrug-resistant tumors and at the blood-brain barrier. Journal of Nuclear Medicine. 2005 Feb;46(2):354-64.
Boonstra R, Timmer-Bosscha H, van Echten-Arends J, van der Kolk DM, van den Berg A, de Jong B, Tew KD, Poppema S, de Vries EG. Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation. British Journal of Cancer. 2004 Jun;90(12):2411-7.
Townsend DM, Shen H, Staros AL, Gate L, Tew KD. Efficacy of a glutathione S-transferase pi-activated prodrug in platinum-resistant ovarian cancer cells. Mol Cancer Ther. 2002 Oct;1(12):1089-95.
Adler V, Yin ZM, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z. Regulation of JNK signaling by GSTp. Embo Journal. 1999 Mar;18(5):1321-34.
Maurer BJ, Ihnat MA, Morgan C, Pullman J, O'Brien C, Johnson SW, Rasey JS, Cornwell MM. Growth of human tumor cells in macroporous microcarriers results in p53-independent, decreased cisplatin sensitivity relative to monolayers. Molecular Pharmacology. 1999 May;55(5):938-47.
Townsend AJ, Fields WR, Doss AJ, Clapper ML, Doehmer J, Morrow CS. Modeling the chemoprotective functions of glutathione S- transferases in cultured cell lines by heterologous expression. Drug Metabolism Reviews. 1999 Jan;31(1):43-69.
Shen HX, Schultz M, Kruh GD, Tew KD. Increased expression of DNA-dependent protein kinase confers resistance to adriamycin. Biochimica Et Biophysica Acta-General Subjects. 1998 Jul 23;1381(2):131-8.
Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC, Chaney SG. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: Correlation with replicative bypass of platinum-DNA adducts. Cancer Research. 1998 Aug 15;58(16):3579-85.
Schultz M, Dutta S, Tew KD. Inhibitors of glutathione S-transferases as therapeutic agents. Advanced Drug Delivery Reviews. 1997 Jul 07;26(2-3):91-104.
Goldstein LJ. MDR1 gene expression in solid tumours. European Journal of Cancer. 1996 Jun;32A(6):1039-50.
Perez RP, Johnson SW, Handel LM, Odwyer PJ, Hamilton TC. Determinants of Cisplatin Sensitivity in Normal Versus Spontaneously Transformed Rat Ovarian Surface Epithelial-Cells. Gynecologic Oncology. 1995 Sep;58(3):312-8.
Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC. Relationship between Platinum-DNA Adduct Formation and Removal and Cisplatin Cytotoxicity in Cisplatin-Sensitive and Cisplatin-Resistant Human Ovarian-Cancer Cells. Cancer Research. 1994 Nov 15;54(22):5911-6.
Perez RP, Hamaguchi K, Tracey PA, Handel LM, Hamilton TC, Godwin AK. Transformation of Rat Ovarian Epithelial and Rat-1 Fibroblast Cell-Lines by Rast24 Does Not Influence Cisplatin Sensitivity. Cancer Research. 1993 Aug 15;53(16):3771-5.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term drug-resistance

drug-resistance expression lines multidrug-resistance in-vitro breast-cancer cancer carcinoma cells glutathione alkylating-agents strand-break repair breast-cancer-cells cell lung-cancer hepatocellular-carcinoma subfamily-b member-1 cytotoxicity cells chemotherapy anticancer agents binding gene-expression drug resistance cis- abcc10 lung-cancer mechanisms human colon p-glycoprotein expression TER 199 TER 286 Ku site-directed mutagenesis glutathione-s-transferase mutations protease inhibitors renal- gallium(iii) complexes catalytic activity multidrug resistance MDR1 P-glycoprotein-blood-brain barrier-perfusion imaging-Ga-67 ethacrynic-acid multicellular DNA-PK molecular mechanisms nucleotide-binding phase-ii zd1839 iressa cell carcinomas apoptosis imaging agents gene tc-99m sestamibi multidrug-resistance gene ovarian-cancer cells kinase Multidrug resistance ABCC10 human mismatch repair c-fos carrier-ligand acid c-jun p53 gene alkylating agents lines resistant polymerase-delta enzymes topotecan signaling pathways interstrand cross-links sensitive cell-lines european case-control Oncology transporter repair oncogene cellular-response stress kinase estrogen-receptor adriamycin pleural mesothelioma glycoprotein uv positron-emission-tomography protein-7 abcc10 aflatoxin b-1 mrp7 ku-autoantigen cancer-cells Ga-68 radiopharmaceutical signaling protein family hydrolysis phosphodiesterase-5 erectile breast cancer spheroids nitrogen mustard-resistant rat-liver induced apoptosis transporter abcg2 human-tissues therapy postmenopausal women modulation stimulates ap-1 activity EGFR Tyrosine kinase inhibitor-Lapatinib-Erlotinib-ABC transporters-MRP7 kidney cells gefitinib chinese-hamster-cells diamminedichloroplatinum(ii) mammalian-cells alpha-class EGFR human-malignant mesothelioma membrane diamminedichloroplatinum(ii) accumulation activated protein-kinase p-glycoprotein atpase mechanism carcinoma estramustine n-terminal delta-domain reversal agents v(d)j recombination tumor-cells selectivity ethacrynic GSTp cycle arrest metabolizing-enzymes inhibitors dependent protein-kinase chemosensitivity cassette kinase pathways pooled analysis multidrug-resistant transduction pathways JNK transporters jun nh2-terminal kinase dna excision-repair enhanced dna-repair pure antiestrogen glutathione s-transferases abrogation phosphorylation tyrosine kinase inhibitor breast cancer resistant protein
Last updated on Wednesday, February 05, 2020